CareCloud
CCLD
Market cap $41.5M

2.56 USD

-0.07

2.66%

At close Oct 18, 4:00 PM EDT

1 day

-2.66%

5 days

6.67%

1 month

-7.58%

3 months

31.28%

6 months

122.61%

Year to date

43.82%

1 year

141.51%

5 years

-35.52%

About: CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.

Employees: 3,600

Information Technology Prepackaged Software

0

Funds holding %

of 6,740 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

129% more call options, than puts

Call options by funds: $71K | Put options by funds: $31K

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

84% more capital invested

Capital invested by funds: $1.76M [Q1] → $3.24M (+$1.48M) [Q2]

18% more funds holding

Funds holding: 28 [Q1] → 33 (+5) [Q2]

1.04% more ownership

Funds ownership: 9.44% [Q1] → 10.48% (+1.04%) [Q2]

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target

$4.50

76%

upside

Avg. target

$4.50

76%

upside

High target

$4.50

76%

upside

1 analyst rating

1 positive

100%

0 neutral

0%

0 negative

0%

Benchmark

Bill Sutherland

60% 1-year accuracy

15 / 25 met price target

76%upside

$4.50

Buy

Maintained

27 Aug 2024

See Analyst Rankings

Financial journalist opinion

CareCloud and ChartSwap Partner to Launch "CareCloud Powered by ChartSwap" to Streamline the Request for Information Process

SOMERSET, N.J., Sept. 30, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc . (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, today announced a strategic partnership with ChartSwap, a leading provider of business-to-business (B2B) medical and billing records exchange, to launch "CareCloud Powered by ChartSwap.” This new collaboration will significantly enhance the way medical records are handled and accessed, enabling CareCloud's providers to focus more on delivering high-quality patient care.

CareCloud and ChartSwap Partner to Launch "CareCloud Powered by ChartSwap" to Streamline the Request for Information Process

CareCloud Announces Approval of Series A Preferred Stock Proposal

SOMERSET, N.J., Sept. 11, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc . (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today reconvened its special meeting (“Special Meeting”) of CareCloud's Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) shareholders. At the Special Meeting, shareholders representing more than two-thirds of the outstanding shares of Series A Preferred Stock approved the preferred stock proposal, which included an amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the “Preferred Stock Proposal”).

CareCloud Announces Approval of Series A Preferred Stock Proposal

Zacks Investment Research

Fast-paced Momentum Stock CareCloud (CCLD) Is Still Trading at a Bargain

CareCloud (CCLD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Fast-paced Momentum Stock CareCloud (CCLD) Is Still Trading at a Bargain

Zacks Investment Research

Buy These 3 Medical Info Systems Stocks to Capitalize on GenAI Boom

Zacks Medical Info Systems industry stocks like Inspire Medical Systems, Clover Health Investments and CareCloud are expected to gain from the GenAI wave.

Buy These 3 Medical Info Systems Stocks to Capitalize on GenAI Boom

Support for Preferred Stock Proposal Hits a New High of 89%, Special Meeting Scheduled for September 11th

SOMERSET, N.J., Aug. 23, 2024 (GLOBE NEWSWIRE) -- C are C loud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that approximately 89% of the shares represented by proxies returned to-date for the Series A Preferred Stock special meeting (“Special Meeting”) have indicated that they are voting “FOR” the amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock (the “Preferred Stock Proposal”). Due to the significantly narrowed gap for passage of the Preferred Stock Proposal, the Special Meeting will be reconvened on Wednesday, September 11, 2024 at 11:00 a.m. Eastern Time.

Support for Preferred Stock Proposal Hits a New High of 89%, Special Meeting Scheduled for September 11th

Zacks Investment Research

Why Fast-paced Mover CareCloud (CCLD) Is a Great Choice for Value Investors

CareCloud (CCLD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Why Fast-paced Mover CareCloud (CCLD) Is a Great Choice for Value Investors

CareCloud, Inc. (CCLD) Q2 2024 Earnings Call Transcript

CareCloud, Inc. (NASDAQ:CCLD ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Mahmud Haq - Founder and Executive Chairman Hadi Chaudhry - CEO Stephen Snyder - President Norman Roth - Interim CFO and Corporate Controller Conference Call Participants Allen Klee - Maxim Group Operator Ladies and gentlemen, welcome to the CareCloud Second Quarter 2024 Results Conference Call. At this time, all participants are in a listen-only mode.

CareCloud, Inc. (CCLD) Q2 2024 Earnings Call Transcript

Zacks Investment Research

CareCloud, Inc. (CCLD) Q2 Earnings and Revenues Beat Estimates

CareCloud, Inc. (CCLD) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to loss of $0.37 per share a year ago.

CareCloud, Inc. (CCLD) Q2 Earnings and Revenues Beat Estimates

CareCloud To Announce Second-Quarter 2024 Results on August 13, 2024

SOMERSET, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, will release its financial results for the quarter ended June 30, 2024 before the market opens on Tuesday, August 13, 2024. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time.

CareCloud To Announce Second-Quarter 2024 Results on August 13, 2024

Voting on CareCloud's Series A Proxy Continues with 82% of Early Proxies Favoring the Proposal

SOMERSET, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- C are C loud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the continuation of proxy solicitation from the holders (the “Series A Preferred Shareholders”) of its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) to approve an amendment to the Company's Certificate of Designations, Preferences and Rights of its' Series A Preferred Stock (the “Preferred Stock Proposal”). With approximately 20% of the shares of Series A Preferred Stock having already returned their proxies, 82% of these shares (up from 72% last week) are in favor of the changes recommended in the Preferred Stock Proposal.

Voting on CareCloud's Series A Proxy Continues with 82% of Early Proxies Favoring the Proposal

See News Rankings

Charts implemented using Lightweight Charts™